Literature DB >> 18375592

The identity and regulation of the mitochondrial permeability transition pore: where the known meets the unknown.

Magdalena Juhaszova1, Su Wang, Dmitry B Zorov, H Bradley Nuss, Marc Gleichmann, Mark P Mattson, Steven J Sollott.   

Abstract

The mitochondrial permeability transition (MPT) pore complex is a key participant in the machinery that controls mitochondrial fate and, consequently, cell fate. The quest for the pore identity has been ongoing for several decades and yet the main structure remains unknown. Established "dogma" proposes that the core of the MPT pore is composed of an association of voltage-dependent anion channel (VDAC) and adenine nucleotide translocase (ANT). Recent genetic knockout experiments contradict this commonly accepted interpretation and provide a basis for substantial revision of the MPT pore identity. There is now sufficient evidence to exclude VDAC and ANT as the main pore structural components. Regarding MPT pore regulation, the role of cyclophilin D is confirmed and ANT may still serve some regulatory function, although the involvement of hexokinase II and creatine kinase remains unresolved. When cell protection signaling pathways are activated, we have found that the Bcl-2 family members relay the signal from glycogen synthase kinase-3 beta onto a target at or in close proximity to the pore. Our experimental findings in intact cardiac myocytes and neurons indicate that the current "dogma" related to the role of Ca2+ in MPT induction requires reevaluation. Emerging evidence suggests that after injury-producing stresses, reactive oxygen species (but not Ca2+) are largely responsible for the pore induction. In this article we discuss the current state of knowledge and provide new data related to the MPT pore structure and regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375592     DOI: 10.1196/annals.1420.023

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  48 in total

1.  Volatile anesthetic post-treatment induces protection via inhibition of glycogen synthase kinase 3β in human neuron-like cells.

Authors:  D Lin; G Li; Z Zuo
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

Review 2.  Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria.

Authors:  Dean P Jones; John J Lemasters; Derick Han; Urs A Boelsterli; Neil Kaplowitz
Journal:  Mol Interv       Date:  2010-04

Review 3.  Bioenergetics and cell death.

Authors:  Yulia Kushnareva; Donald D Newmeyer
Journal:  Ann N Y Acad Sci       Date:  2010-07       Impact factor: 5.691

Review 4.  Regulation and pharmacology of the mitochondrial permeability transition pore.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Yael Yaniv; H Bradley Nuss; Su Wang; Steven J Sollott
Journal:  Cardiovasc Res       Date:  2009-05-15       Impact factor: 10.787

Review 5.  Role of glycogen synthase kinase-3beta in cardioprotection.

Authors:  Magdalena Juhaszova; Dmitry B Zorov; Yael Yaniv; H Bradley Nuss; Su Wang; Steven J Sollott
Journal:  Circ Res       Date:  2009-06-05       Impact factor: 17.367

Review 6.  Uncovering the role of VDAC in the regulation of cell life and death.

Authors:  Varda Shoshan-Barmatz; Nurit Keinan; Hilal Zaid
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

7.  BNIP3 mediates cell death by different pathways following localization to endoplasmic reticulum and mitochondrion.

Authors:  Lu Zhang; Li Li; Han Liu; Joseph L Borowitz; Gary E Isom
Journal:  FASEB J       Date:  2009-06-17       Impact factor: 5.191

8.  Integrins protect cardiomyocytes from ischemia/reperfusion injury.

Authors:  Hideshi Okada; N Chin Lai; Yoshitaka Kawaraguchi; Peter Liao; Jeffrey Copps; Yasuo Sugano; Sunaho Okada-Maeda; Indroneal Banerjee; Jan M Schilling; Alexandre R Gingras; Elizabeth K Asfaw; Jorge Suarez; Seok-Min Kang; Guy A Perkins; Carol G Au; Sharon Israeli-Rosenberg; Ana Maria Manso; Zheng Liu; Derek J Milner; Stephen J Kaufman; Hemal H Patel; David M Roth; H Kirk Hammond; Susan S Taylor; Wolfgang H Dillmann; Joshua I Goldhaber; Robert S Ross
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

9.  Mitochondrial dysfunction increases allergic airway inflammation.

Authors:  Leopoldo Aguilera-Aguirre; Attila Bacsi; Alfredo Saavedra-Molina; Alexander Kurosky; Sanjiv Sur; Istvan Boldogh
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

Review 10.  Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.

Authors:  D Morin; R Assaly; S Paradis; A Berdeaux
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.